How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research More Diagnostics in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
16 clearance records and 0 recall records in the covered releases, across 1 source company names and 7 product codes. Dated history runs from Jul 26, 1993 to Jan 30, 2008.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| MYCOPHENOLIC ACID CONTROL, LEVEL 1, 2, 3, 4, 4-LEVELK072257 · LAS | More Diagnostics | 510(k) | Jan 30, 2008FDA decision date |
| RAP/TAC/CSA CONTROL - LEVEL 1,2,3,4K050125 · JJY | More Diagnostics | 510(k) | Mar 18, 2005FDA decision date |
| CARDIAC MARKERS CONTROL (SINGLE USE)-LEVELS, 1,2,3, MODELS NUMBER 175-1, 175-2, 175-3K982845 · JJT | More Diagnostics | 510(k) | Aug 21, 1998FDA decision date |
| IMMUNOSUPPRESSANT (WHOLE BLOOD) CONTROL, LEVEL 1 250-1, IMMUNOSUPPRESSANT (WHOLE BLOOS) CONTROL, LEVEL 2, 250-2, IMMUN\SK980331 · DIF | More Diagnostics | 510(k) | Mar 16, 1998FDA decision date |
| CARDIAC MARKERS CONTROL - LEVEL 1, LEVEL 2, LEVEL 3, TRI-LEVELK972976 · JJT | More Diagnostics | 510(k) | Aug 29, 1997FDA decision date |
| LEAD CONTROL (WHOLE BLOOD) LEVELS 1,2,3,4K970778 · JJX | More Diagnostics | 510(k) | Apr 17, 1997FDA decision date |
| FIBRINOGEN CONTROL (HUMAN) LEVEL 1, 2, 3K946193 · GIL | More Diagnostics | 510(k) | Aug 24, 1995FDA decision date |
| MULTI-LEVEL CONTROL FOR FIBRIN DEGRADATION PRODUCTSK943571 · DAP | More Diagnostics | 510(k) | Jun 15, 1995FDA decision date |
| SERUM BILIRUBIN CONTROL- LEVEL 1, 2 AND 3K944999 · JJX | More Diagnostics | 510(k) | Jun 6, 1995FDA decision date |
| SERUM VOLATILES CONTROL - LEVELS 1 AND 2K941698 · JJY | More Diagnostics | 510(k) | Jul 28, 1994FDA decision date |
| WHOLE BLOOD VOLATILES CONTROL, LEVELS 1 AND 2K941876 · JJY | More Diagnostics | 510(k) | Jul 28, 1994FDA decision date |
| FIBRIN(OGEN) FDP CONTROL LEVEL 1 & LEVEL 2K932657 · DAP | More Diagnostics | 510(k) | Nov 2, 1993FDA decision date |
| LD-1 ISOENZYME CONTROL (HUMAN) LEVEL 1 & 2K932660 · JJX | More Diagnostics | 510(k) | Oct 28, 1993FDA decision date |
| CKMB ISOENZYME CONTROL(HUMAN) LEVEL 1,2,& 3K932658 · JJX | More Diagnostics | 510(k) | Jul 28, 1993FDA decision date |
| MULTI LEVEL CONTROL FOR CKMB ISOENSYME IN SYRUMK932659 · JJX | More Diagnostics | 510(k) | Jul 28, 1993FDA decision date |
| CYCLOSPORINE (WHOLE BLOOD) CONTROL-PEDIATRIC LEVELK932662 · LAS | More Diagnostics | 510(k) | Jul 26, 1993FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.